{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:22:45Z","timestamp":1793146965312,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.annder.2026.103512","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:50:08Z","timestamp":1780527008000},"page":"103512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Topical JAK inhibitors in the lichen planus spectrum: a systematic review"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2877-5919","authenticated-orcid":false,"given":"M.","family":"Shanshal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Uthayakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2026.103512_b0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/jid.2009.42","article-title":"Lichenoid tissue reaction\/interface dermatitis: clinical and histological perspectives","volume":"129","author":"Sontheimer","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jaad.2018.02.010","article-title":"Lichen planus and lichenoid dermatoses: clinical overview and molecular basis","volume":"79","author":"Tziotzios","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.abd.2021.08.008","article-title":"Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features","volume":"97","author":"Fechine","year":"2022","journal-title":"Ann Bras Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/cup.13112","article-title":"Lichen planopilaris and frontal fibrosing alopecia cannot be differentiated by histopathology","volume":"45","author":"G\u00e1lvez-Canseco","year":"2018","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2026.103512_b0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ced\/llae339","article-title":"Quality-of-life assessment and the impact of early diagnosis and treatment in lichen planopilaris: a systematic review","volume":"50","author":"Kelati","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0973-029X.84474","article-title":"Oral lichen planus: an update on pathogenesis and treatment","volume":"15","author":"Lavanya","year":"2011","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.annder.2026.103512_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7561","article-title":"IFN-\u03b3 enhances cell-mediated cytotoxicity against keratinocytes via JAK2\/STAT1 in lichen planus","volume":"11","author":"Shao","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.annder.2026.103512_b0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/exd.14226","article-title":"The inflammation in cutaneous lichen planus is dominated by IFN\u2010\u03b3 and IL\u201021\u2014a basis for therapeutic JAK1 inhibition","volume":"30","author":"Pietschke","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2018.11.022","article-title":"The influence of interferon on healthy and diseased skin","volume":"132","author":"Hile","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.annder.2026.103512_b0050","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/jid.2008.251","article-title":"Chemokines in the pathogenesis of lichenoid tissue reactions","volume":"129","author":"Meller","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0002-9440(10)63649-8","article-title":"Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES\/CCL5 and IP-10\/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism","volume":"163","author":"Iijima","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.annder.2026.103512_b0060","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0560.2006.00527.x","article-title":"Type I interferon-associated cytotoxic inflammation in lichen planus","volume":"33","author":"Wenzel","year":"2006","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.annder.2026.103512_b0065","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1080\/09546634.2022.2116926","article-title":"JAK inhibitors in lichen planus: a review of pathogenesis and treatments","volume":"33","author":"Motamed-Sanaye","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2026.103512_b0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/12034754231156100","article-title":"The use of Janus kinase inhibitors for lichen planus: an evidence-based review","volume":"27","author":"Abduelmula","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.annder.2026.103512_b0075","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","article-title":"A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring","volume":"13","author":"Samuel","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.annder.2026.103512_b0080","doi-asserted-by":"crossref","first-page":"10592","DOI":"10.3390\/ijms262110592","article-title":"Topical ruxolitinib and delgocitinib versus systemic JAK inhibitors: a comparative safety review","volume":"26","author":"B\u00f6ll","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.annder.2026.103512_b0085","article-title":"randomized controlled trial of the topical JAK inhibitor delgocitinib cream in patients with frontal fibrosing alopecia","author":"Martin","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0090","unstructured":"ClinicalTrials.gov. A study to evaluate the efficacy and safety of ruxolitinib cream in participants with cutaneous lichen planus (LP). Identifier NCT05593432. Incyte Corporation. Results first posted 24 Oct 2024. Available at: https:\/\/clinicaltrials.gov\/study\/NCT05593432 [accessed 3 Nov 2025]."},{"key":"10.1016\/j.annder.2026.103512_b0095","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaad.2024.01.060","article-title":"Topical tofacitinib for patients with lichen planopilaris and\/or frontal fibrosing alopecia","volume":"90","author":"Chen","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2024.09.032","article-title":"Topical ruxolitinib in the management of frontal fibrosing alopecia and\/or lichen planopilaris: a single-center retrospective cohort study","volume":"92","author":"Williams","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0105","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jaad.2020.05.104","article-title":"Tofacitinib in the treatment of lichen planopilaris: a retrospective review","volume":"83","author":"Plante","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdcr.2023.07.037","article-title":"Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: a case series and review of the literature","volume":"40","author":"Dunn","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2026.103512_b0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jdcr.2024.04.034","article-title":"The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: a case report","volume":"50","author":"Desai","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2026.103512_b0120","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jvc2.515","article-title":"Successful treatment of recalcitrant follicular lichen planus (lichen planopilaris) with the topical JAK 1\/2 inhibitor ruxolitinib","volume":"4","author":"Fetter","year":"2025","journal-title":"JEADV Clin Pract"},{"key":"10.1016\/j.annder.2026.103512_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2024.103303","article-title":"Successful treatment of resistant lichen planopilaris with topical tofacitinib monotherapy","volume":"151","author":"Janu\u0161onyt\u0117","year":"2024","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2026.103512_b0130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jid.2022.01.015","article-title":"Ruxolitinib cream in the treatment of cutaneous lichen planus: a prospective, open-label study","volume":"142","author":"Brumfiel","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0135","article-title":"Efficacy of topical tofacitinib 2% cream in the treatment of nail lichen planus","author":"Iorizzo","year":"2025","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2026.103512_b0140","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2147\/CCID.S542446","article-title":"Successful treatment of childhood nail lichen planus with ruxolitinib cream: a case report","volume":"18","author":"Sheng","year":"2025","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.annder.2026.103512_b0145","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jdcr.2023.10.012","article-title":"Recalcitrant lichen planus pigmentosus treated with topical ruxolitinib","volume":"42","author":"Cornman","year":"2023","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2026.103512_b0150","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1111\/1346-8138.17151","article-title":"Lichen planus pigmentosus successfully treated with topical delgocitinib","volume":"51","author":"Asai","year":"2024","journal-title":"J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963826000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963826000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:32:24Z","timestamp":1788985944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963826000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0151963826000463"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2026.103512","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical JAK inhibitors in the lichen planus spectrum: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2026.103512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"103512"}}